|
1
|
Cho B, Lim Y, Lee DY, Park SY, Lee H, Kim
WH, Yang H, Bang YJ and Jeoung DI: Identification and
characterization of a novel cancer/testis antigen gene CAGE.
Biochem Biophys Res Commun. 292:715–726. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim Y and Jeoung D: Role of CAGE, a novel
cancer/testis antigen, in various cellular processes, including
tumorigenesis, cytolytic T lymphocyte induction, and cell motility.
J Microbiol Biotechnol. 18:600–610. 2008.
|
|
3
|
Kim Y, Park H, Park D, Lee YS, Choe J,
Hahn JH, Lee H, Kim YM and Jeoung D: Cancer/testis antigen CAGE
exerts negative regulation on p53 expression through HDAC2 and
confers resistance to anti-cancer drugs. J Biol Chem.
285:25957–25968. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Por E, Byun HJ, Lee EJ, Lim JH, Jung SY,
Park I, Kim YM, Jeoung DI and Lee H: The cancer/testis antigen CAGE
with oncogenic potential stimulates cell proliferation by
up-regulating cyclins D1 and E in an AP-1- and E2F-dependent
manner. J Biol Chem. 285:14475–14485. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Caballero OL and Chen YT: Cancer/testis
(CT) antigens: potential targets for immunotherapy. Cancer Sci.
100:2014–2021. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Filpula D: Antibody engineering and
modification technologies. Biomol Eng. 24:201–215. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dreier B and Plückthun A: Ribosome
display: a technology for selecting and evolving proteins from
large libraries. Methods Mol Biol. 687:283–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rothe A, Nathanielsz A, Hosse RJ,
Oberhäuser F, Strandmann EP, Engert A, Hudson PJ and Power BE:
Selection of human anti-CD28 scFvs from a T-NHL related scFv
library using ribosome display. J Biotechnol. 130:448–454. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rothe A, Nathanielsz A, Oberhäuser F, von
Pogge SE, Engert A, Hudson PJ and Power BE: Ribosome display and
selection of human anti-cD22 scFvs derived from an acute
lymphocytic leukemia patient. Biol Chem. 389:433–439. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li F, Su P, Lin C, Li H, Cheng J and Shi
D: Ribosome display and selection of human anti-placental growth
factor scFv derived from ovarian cancer patients. Protein Pept
Lett. 17:585–590. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He M, Cooley N, Jackson A and Taussig MJ:
Production of human single-chain antibodies by ribosome display.
Methods Mol Biol. 248:177–189. 2004.PubMed/NCBI
|
|
12
|
He M and Taussig MJ:
Antibody-ribosome-mRNA (ARM) complexes as efficient selection
particles for in vitro display and evolution of antibody combining
sites. Nucleic Acids Res. 25:5132–5134. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Friguet B, Chaffotte AF, Djavadi-Ohaniance
L and Goldberg ME: Measurements of the true affinity constant in
solution of antigen-antibody complexes by enzyme-linked
immunosorbent assay. J Immunol Methods. 77:305–319. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan XH and Xu ZR: Production of human
single-chain variable fragment (scFv) antibody specific for digoxin
by ribosome display. Indian J Biochem Biophys. 42:350–357.
2005.PubMed/NCBI
|
|
15
|
Yoong J, Michael M and Leong T: Targeted
therapies for gastric cancer: current status. Drugs. 71:1367–1384.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Andratschke M, Luebbers CW, Johannson V,
Schmitt B, Mack B, Zeidler R, Lang S, Wollenberg B and Gildehaus
FJ: Biodistribution of 131I-labeled anti-CK8 monoclonal antibody in
HNSCC in xenotransplanted SCID mice. Anticancer Res. 31:3315–3321.
2011.PubMed/NCBI
|
|
17
|
Kreitman RJ and Pastan I: Antibody fusion
proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotox.
Clin Cancer Res. 17:6398–6405. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ricart AD: Antibody-drug conjugates of
calicheamicin derivative: gemtuzumab ozogamicin and inotuzumab
ozogamicin. Clin Cancer Res. 17:6417–6427. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bernett MJ, Karki S, Moore GL, et al:
Engineering fully human monoclonal antibodies from murine variable
regions. J Mol Biol. 396:1474–1490. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamashita M, Katakura Y and Shirahata S:
Recent advances in the generation of human monoclonal antibody.
Cytotechnology. 55:55–60. 2007. View Article : Google Scholar
|
|
21
|
He M and Khan F: Ribosome display:
next-generation display technologies for production of antibodies
in vitro. Expert Rev Proteomics. 2:421–430. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zahnd C, Amstutz P and Plückthun A:
Ribosome display: selecting and evolving proteins in vitro that
specifically bind to a target. Nat Methods. 4:269–279. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
He M and Taussig MJ: Selection of
recombinant antibodies by eukaryotic ribosome display. Methods Mol
Biol. 484:193–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Suri A: Cancer testis antigens - their
importance in immunotherapy and in the early detection of cancer.
Expert Opin Biol Ther. 6:379–389. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cho B, Lee H, Jeong S, Bang YJ, Lee HJ,
Hwang KS, Kim HY, Lee YS, Kang GH and Jeoung DI: Promoter
hypomethylation of a novel cancer/testis antigen gene CAGE is
correlated with its aberrant expression and is seen in premalignant
stage of gastric carcinoma. Biochem Biophys Res Commun. 307:52–63.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Iwata T, Fujita T, Hirao N, et al:
Frequent immune responses to a cancer/testis antigen, CAGE, in
patients with microsatellite instability-positive endometrial
cancer. Clin Cancer Res. 11:3949–3957. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Accardi L and Di Bonito P: Antibodies in
single-chain format against tumour-associated antigens: present and
future applications. Curr Med Chem. 17:1730–1755. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ullman CG, Frigotto L and Cooley RN: In
vitro methods for peptide display and their applications. Brief
Funct Genomics. 10:125–134. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lee MS, Kwon MH, Kim KH, Shin HJ, Park S
and Kim HI: Selection of scFvs specific for HBV DNA polymerase
using ribosome display. J Immunol Methods. 284:147–157. 2004.
View Article : Google Scholar : PubMed/NCBI
|
